Merit predicts better than expected results:
This article was originally published in Clinica
Merit Medical Systems, which makes disposable products for use in cardiology and radiology, says its third-quarter results will exceed previous guidance. The South Jordan, Utah company has already exceeded earnings guidance of $0.12 per share in the first two months of the quarter. The third quarter is traditionally its slowest in terms of revenue growth, the company says. "Our business is somewhat resilient to the economic and trying times we are experiencing and continues to be strong," said Fred Lampropoulos, Merit's president. The company also expects a strong fourth quarter, owing to distribution agreements, new product introductions and continued growth in existing product lines.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.